AIM IMMUNOTECH INC. Other Accrued Liabilities, Current
AIM IMMUNOTECH INC. (AIM) had Other Accrued Liabilities, Current of $73.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Other Accrued Liabilities, Current $73.00K.
- 2026-03-31: Other Accrued Liabilities, Current $73.00K.
- 2025-12-31: Other Accrued Liabilities, Current $190.00K.
- 2025-09-30: Other Accrued Liabilities, Current $75.00K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $73.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $73.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $190.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $75.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $62.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $54.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $33.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $37.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $8.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $36.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $106.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $82.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $92.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $203.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $199.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $130.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $159.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $207.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $182.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $177.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $203.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $316.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $117.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $136.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $224.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $180.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $430.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $362.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $374.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $302.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $205.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $213.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $532.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $581.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $579.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $586.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $511.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $489.00K 10-K · filed 2018-03-30 |
| 2016-09-30 | $274.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $288.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $226.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $228.00K 10-K · filed 2017-03-31 |
| 2014-12-31 | $123.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |